Clinical Trial Update: Serum Vasopressin Levels and Severe Hemorrhagic Shock

View source ↗

Summary

A clinical trial investigating serum vasopressin levels in severe hemorrhagic shock has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemorrhagic Shock

Snippet

Sponsor: Poudre Valley Health System | Conditions: Injury | Status: WITHDRAWN